This study was designed to determine serum Fetuin-A levels and establish whether serum Fetuin-A level is related with insulin resistance, oxidative stress, ovarian hyperandrogenism and dyslipidemia in women with polycystic ovary syndrome (PCOS). Twenty-two patients with PCOS and twenty-one healthy control women were evaluated in this controlled clinical study. Serum Fetuin-A, lipid fractions, glucose, insulin, malondialdehyde (MDA), myeloperoxidase (MPO), glutathione (GSH), superoxide dismutase (SOD) and other hormone (gonadotropins, androgens) levels were measured. The estimate of insulin resistance was calculated by homeostasis model assessment (HOMA-R). The women with PCOS had significantly higher serum fasting glucose, insulin, luteinizing hormone (LH), MDA, Fetuin-A levels, and LH/follicle-stimulating hormone (FSH) ratio, free androgen index (FAI), HOMA-IR than healthy women. However, sex hormone-binding globulin (SHBG) and GSH levels were significantly lower in patients with PCOS compared with controls. Fetuin-A was positively correlated with insulin, HOMA-IR and FAI. Multiple regression analysis revealed that FAI was strong predictor of serum Fetuin-A level. Serum Fetuin-A level was related with insulin resistance and ovarian hyperandrogenism in women with PCOS. These results suggest that Fetuin-A may have a role in triggering the processes leading to insulin resistance and androgen excess in PCOS.
23 June 2025 in Clinical and Experimental Obstetrics & Gynecology
Background: This study aimed to investigate serum levels of calcitonin gene-related peptide (CGRP) and explore potential associations between serum CGRP, adiponectin, and ghrelin concentrations in patients with preeclampsia. Methods: This study evaluated 43 normotensive healthy pregnant women and 36 pregnant women diagnosed with preeclampsia. Serum concentrations of CGRP, adiponectin, and ghrelin were measured in both groups during the third trimester of pregnancy. Results: Serum concentrations of CGRP were significantly elevated in the preeclampsia group compared to the control group. Conversely, the preeclampsia group exhibited significantly decreased serum levels of adiponectin and ghrelin relative to the controls. No significant correlation was observed between serum CGRP levels and adiponectin or ghrelin levels in either the preeclampsia or control groups. Conclusions: Our study demonstrates a considerable increase in serum CGRP concentrations in patients with preeclampsia compared to the control group. These outcomes strongly indicate that CGRP may play a pivotal role in the pathogenesis of preeclampsia.